UPDATE 2-Merck/Moderna cancer vaccine cuts melanoma death or recurrence risk by 42%, shares fall

2

* Combination also reduced risk of cancer spread by 38% in study of more than 1,100 patients * First late-stage data showing a personalized cancer vaccine improved outcomes when added to immune

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)